173 related articles for article (PubMed ID: 37192001)
21. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
Front Immunol; 2020; 11():835. PubMed ID: 32457755
[TBL] [Abstract][Full Text] [Related]
22. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
[TBL] [Abstract][Full Text] [Related]
23. Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?
Han S; Li X; Qiu B; Jiang T; Wu A
J Neurooncol; 2015 Aug; 124(1):45-55. PubMed ID: 26007164
[TBL] [Abstract][Full Text] [Related]
24. Immune landscapes associated with different glioblastoma molecular subtypes.
Martinez-Lage M; Lynch TM; Bi Y; Cocito C; Way GP; Pal S; Haller J; Yan RE; Ziober A; Nguyen A; Kandpal M; O'Rourke DM; Greenfield JP; Greene CS; Davuluri RV; Dahmane N
Acta Neuropathol Commun; 2019 Nov; 7(1):203. PubMed ID: 31815646
[TBL] [Abstract][Full Text] [Related]
25. Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone.
Jungk C; Mock A; Exner J; Geisenberger C; Warta R; Capper D; Abdollahi A; Friauf S; Lahrmann B; Grabe N; Beckhove P; von Deimling A; Unterberg A; Herold-Mende C
BMC Med; 2016 Oct; 14(1):170. PubMed ID: 27782828
[TBL] [Abstract][Full Text] [Related]
26. Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.
Luoto S; Hermelo I; Vuorinen EM; Hannus P; Kesseli J; Nykter M; Granberg KJ
Cancer Res; 2018 Oct; 78(19):5574-5585. PubMed ID: 29921698
[TBL] [Abstract][Full Text] [Related]
27. Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.
Kiyokawa J; Kawamura Y; Ghouse SM; Acar S; Barçın E; Martínez-Quintanilla J; Martuza RL; Alemany R; Rabkin SD; Shah K; Wakimoto H
Clin Cancer Res; 2021 Feb; 27(3):889-902. PubMed ID: 33257429
[TBL] [Abstract][Full Text] [Related]
28. Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma.
Lara-Velazquez M; Zarco N; Carrano A; Phillipps J; Norton ES; Schiapparelli P; Al-Kharboosh R; Rincon-Torroella J; Jeanneret S; Corona T; Segovia J; Jentoft ME; Chaichana KL; Asmann YW; Quiñones-Hinojosa A; Guerrero-Cazares H
Neuro Oncol; 2021 Apr; 23(4):599-610. PubMed ID: 33249487
[TBL] [Abstract][Full Text] [Related]
29. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
30. DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma.
Adeberg S; Knoll M; Koelsche C; Bernhardt D; Schrimpf D; Sahm F; König L; Harrabi SB; Hörner-Rieber J; Verma V; Bewerunge-Hudler M; Unterberg A; Sturm D; Jungk C; Herold-Mende C; Wick W; von Deimling A; Debus J; Rieken S; Abdollahi A
Acta Neuropathol; 2022 Jul; 144(1):129-142. PubMed ID: 35660939
[TBL] [Abstract][Full Text] [Related]
31. Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma.
van Dijken BRJ; Schuuring B; Jeltema HR; van Laar PJ; Enting RH; Dierckx RAJO; Stormezand GN; van der Hoorn A
Neuroradiology; 2022 Feb; 64(2):247-252. PubMed ID: 34114063
[TBL] [Abstract][Full Text] [Related]
32. MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization.
Hansen LJ; Yang R; Roso K; Wang W; Chen L; Yang Q; Pirozzi CJ; He Y
Sci Rep; 2022 Mar; 12(1):4183. PubMed ID: 35264604
[TBL] [Abstract][Full Text] [Related]
33. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
[TBL] [Abstract][Full Text] [Related]
34. Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade.
Chen Z; Herting CJ; Ross JL; Gabanic B; Puigdelloses Vallcorba M; Szulzewsky F; Wojciechowicz ML; Cimino PJ; Ezhilarasan R; Sulman EP; Ying M; Ma'ayan A; Read RD; Hambardzumyan D
Glia; 2020 Oct; 68(10):2148-2166. PubMed ID: 32639068
[TBL] [Abstract][Full Text] [Related]
35. Differential microglia and macrophage profiles in human IDH-mutant and -wild type glioblastoma.
Poon CC; Gordon PMK; Liu K; Yang R; Sarkar S; Mirzaei R; Ahmad ST; Hughes ML; Yong VW; Kelly JJP
Oncotarget; 2019 May; 10(33):3129-3143. PubMed ID: 31139325
[TBL] [Abstract][Full Text] [Related]
36. Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
Simonds EF; Lu ED; Badillo O; Karimi S; Liu EV; Tamaki W; Rancan C; Downey KM; Stultz J; Sinha M; McHenry LK; Nasholm NM; Chuntova P; Sundström A; Genoud V; Shahani SA; Wang LD; Brown CE; Walker PR; Swartling FJ; Fong L; Okada H; Weiss WA; Hellström M
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083417
[TBL] [Abstract][Full Text] [Related]
37. Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms.
Xuan W; Lesniak MS; James CD; Heimberger AB; Chen P
Trends Immunol; 2021 Apr; 42(4):280-292. PubMed ID: 33663953
[TBL] [Abstract][Full Text] [Related]
38. Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma.
Tafani M; Di Vito M; Frati A; Pellegrini L; De Santis E; Sette G; Eramo A; Sale P; Mari E; Santoro A; Raco A; Salvati M; De Maria R; Russo MA
J Neuroinflammation; 2011 Apr; 8():32. PubMed ID: 21489226
[TBL] [Abstract][Full Text] [Related]
39. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
40. The clinical characteristics and prognostic factors of multiple lesions in glioblastomas.
Tunthanathip T; Sangkhathat S; Tanvejsilp P; Kanjanapradit K
Clin Neurol Neurosurg; 2020 Aug; 195():105891. PubMed ID: 32480195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
